CyberLogic, Inc.

CyberLogic develops FDA-approved ultrasound bone densitometry devices and advanced ultrasound simulation software. The company's UltraScan 650 is the first and only FDA-approved ultrasound bone densitometer that measures bone mineral density (BMD) using patented NTD technology, delivering DXA-equivalent accuracy without radiation exposure. The device operates in under 10 seconds, is portable and USB-powered, making it suitable for clinical osteoporosis screening and monitoring in primary care, women's health, and population screening programs. CyberLogic also offers the Wave-series software (Wave2000, Wave2500, Wave3000) for high-fidelity 2D and 3D viscoelastic wave modeling in biomedical imaging, tissue characterization, nondestructive testing, transducer design, and material characterization. Backed by 30+ years of research and peer-reviewed validation, CyberLogic serves hospitals, universities, research labs, and engineers worldwide.